Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Någren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO.

Brain. 2008 Jul;131(Pt 7):1845-53. doi: 10.1093/brain/awn107. Epub 2008 Jun 25.

PMID:
18583368
2.

Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study.

Rastas S, Pirttilä T, Mattila K, Verkkoniemi A, Juva K, Niinistö L, Länsimies E, Sulkava R.

Neurobiol Aging. 2010 Jan;31(1):1-7. doi: 10.1016/j.neurobiolaging.2008.02.020. Epub 2008 Apr 1.

PMID:
18378359
3.

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.

Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS.

Lancet Neurol. 2008 Apr;7(4):310-8. doi: 10.1016/S1474-4422(08)70046-2. Epub 2008 Feb 28.

PMID:
18296124
4.

Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older.

Rastas S, Verkkoniemi A, Polvikoski T, Juva K, Niinistö L, Mattila K, Länsimies E, Pirttilä T, Sulkava R.

Stroke. 2007 May;38(5):1454-60. Epub 2007 Mar 29.

PMID:
17395865
5.

Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old Finnish population.

Tanskanen M, Kiuru-Enari S, Tienari P, Polvikoski T, Verkkoniemi A, Rastas S, Sulkava R, Paetau A.

Amyloid. 2006 Sep;13(3):164-9.

PMID:
17062383
6.

Association between blood pressure and survival over 9 years in a general population aged 85 and older.

Rastas S, Pirttilä T, Viramo P, Verkkoniemi A, Halonen P, Juva K, Niinistö L, Mattila K, Länsimies E, Sulkava R.

J Am Geriatr Soc. 2006 Jun;54(6):912-8.

PMID:
16776785
7.

Tupakka, nikotiini ja kognitiiviset toiminnot.

Patja K, Verkkoniemi A.

Duodecim. 2006;122(6):665-9. Finnish. No abstract available.

PMID:
16683361
8.

Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study.

Polvikoski T, Sulkava R, Rastas S, Sutela A, Niinistö L, Notkola IL, Verkkoniemi A, Viramo P, Juva K, Haltia M.

Neuroepidemiology. 2006;26(2):76-82. Epub 2005 Dec 13.

PMID:
16352910
9.

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S.

Neuropathol Appl Neurobiol. 2005 Dec;31(6):589-99.

PMID:
16281907
10.

[Genetics of Alzheimer disease].

Verkkoniemi A, Kalimo H, Viitanen M.

Duodecim. 2005;121(3):326-7; author reply 327. Finnish. No abstract available.

PMID:
15787292
11.

Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+.

Rastas S, Mattila K, Verkkoniemi A, Niinistö L, Juva K, Sulkava R, Länsimies E.

BMC Geriatr. 2004 Mar 29;4:1.

12.

Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.

Verkkoniemi A, Ylikoski R, Rinne JO, Somer M, Hietaharju A, Erkinjuntti T, Viitanen M, Kalimo H, Haltia M.

J Neurol Sci. 2004 Mar 15;218(1-2):29-37.

PMID:
14759630
13.

Does apolipoprotein E influence learning and memory in the nondemented oldest old?

Salo A, Ylikoski R, Verkkoniemi A, Polvikoski T, Juva K, Rastas S, Kontula K, Kainulainen K, Niinistö L, Notkola IL, Sulkava R.

Int Psychogeriatr. 2001 Dec;13(4):451-9.

PMID:
12003251
14.

ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.

Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola IL, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ.

Am J Med Genet. 2002 Apr 8;114(3):288-91.

PMID:
11920850
15.

[New variant of Alzheimer's disease].

Verkkoniemi A, Somer M, Haltia M.

Duodecim. 1998;114(24):2509-11. Finnish. No abstract available.

PMID:
11757118
16.

Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.

Myllykangas L, Polvikoski T, Sulkava R, Notkola IL, Rastas S, Verkkoniemi A, Tienari PJ, Niinistö L, Hardy J, Pérez-Tur J, Kontula K, Haltia M.

Ann Med. 2001 Oct;33(7):486-92.

PMID:
11680797
17.

Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study.

Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinistö L, Verkkoniemi A, Kainulainen K, Kontula K, Pérez-Tur J, Hardy J, Haltia M.

Neurology. 2001 Jun 26;56(12):1690-6.

PMID:
11425935
18.

Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype.

Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, Haltia M.

J Neuropathol Exp Neurol. 2001 May;60(5):483-92.

PMID:
11379823
19.

Delirium in the non-demented oldest old in the general population: risk factors and prognosis.

Rahkonen T, Eloniemi-Sulkava U, Halonen P, Verkkoniemi A, Niinistö L, Notkola IL, Sulkava R.

Int J Geriatr Psychiatry. 2001 Apr;16(4):415-21.

PMID:
11333430
20.

Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over.

Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R.

Int Psychogeriatr. 2000 Sep;12(3):379-87.

PMID:
11081958
21.

Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations.

Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, Verkkoniemi A, Kalimo H, Somer M, Paetau A, Martin JJ, Van Broeckhoven C, Golde T, Hardy J, Haltia M, Revesz T.

Ann Neurol. 2000 Nov;48(5):806-8.

PMID:
11079548
22.

Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over.

Myllykangas L, Polvikoski T, Sulkava R, Verkkoniemi A, Tienari P, Niinistö L, Kontula K, Hardy J, Haltia M, Pérez-Tur J.

Neurosci Lett. 2000 Oct 13;292(3):195-8.

PMID:
11018310
23.

Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?

Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M, Pirskanen M, Sulkava R, Verkkoniemi A, Soininen H.

Eur J Hum Genet. 2000 Apr;8(4):259-66.

24.

Variant Alzheimer's disease with spastic paraparesis: clinical characterization.

Verkkoniemi A, Somer M, Rinne JO, Myllykangas L, Crook R, Hardy J, Viitanen M, Kalimo H, Haltia M.

Neurology. 2000 Mar 14;54(5):1103-9.

PMID:
10720282
25.

APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.

Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R.

Neurology. 2000 Jan 25;54(2):412-5.

PMID:
10668704
26.

Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population.

Myllykangas L, Polvikoski T, Sulkava R, Verkkoniemi A, Crook R, Tienari PJ, Pusa AK, Niinistö L, O'Brien P, Kontula K, Hardy J, Haltia M, Pérez-Tur J.

Ann Neurol. 1999 Sep;46(3):382-90.

PMID:
10482269
27.

The prevalence and associates of depressive disorders in the oldest-old Finns.

Päivärinta A, Verkkoniemi A, Niinistö L, Kivelä SL, Sulkava R.

Soc Psychiatry Psychiatr Epidemiol. 1999 Jul;34(7):352-9.

PMID:
10477955
28.

A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, Farrer M, Hutton M, Lincoln S, Hardy J, Gwinn K, Somer M, Paetau A, Kalimo H, Ylikoski R, Pöyhönen M, Kucera S, Haltia M.

Nat Med. 1998 Apr;4(4):452-5.

PMID:
9546792
29.

Depression measured by the Zung Depression Status Inventory is very rare in a Finnish population aged 85 years and over.

Kiljunen M, Sulkava R, Niinistö L, Polvikoski T, Verkkoniemi A, Halonen P.

Int Psychogeriatr. 1997 Sep;9(3):359-68.

PMID:
9513033
30.

[Tick-borne viral encephalitis].

Verkkoniemi A, Silén T, Valtonen M.

Duodecim. 1997;113(4):329-31. Finnish. No abstract available.

PMID:
11370104
31.

APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+.

Sulkava R, Kainulainen K, Verkkoniemi A, Niinistö L, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K.

Neurobiol Aging. 1996 May-Jun;17(3):373-6.

PMID:
8725898
32.

Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K.

N Engl J Med. 1995 Nov 9;333(19):1242-7.

Supplemental Content

Loading ...
Support Center